Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Mitral valve replacement Stories

2014-04-09 16:26:11

ROSEVILLE, Minn., April 9, 2014 /PRNewswire/ -- Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company developing technologies for transcatheter mitral valve replacement, announced today that it has secured $25 million in an oversubscribed Series C financing led by Apple Tree Partners, along with Boulle Group members and other existing investors. Proceeds will be used for validation of Tendyne's novel Transcatheter Mitral Valve Implant to treat...

2014-01-30 12:28:23

DETROIT, Jan. 30, 2014 /PRNewswire/ -- For the first time in the U.S., doctors at Henry Ford Hospital have used an artificial heart valve designed for aortic valve replacement to repair a mitral valve that was narrowed with calcium buildup. And they did it all through a catheter. (Photo: http://photos.prnewswire.com/prnh/20140130/DE56074 ) Approximately 5 million people in the U.S. are diagnosed with heart valve disease each year. With an aging population that is often too frail...

2013-12-19 12:28:48

Valve repair can improve the quality of life for patients with debilitating mitral valve disease HARRISBURG, Pa., Dec. 19, 2013 /PRNewswire-iReach/ -- Last week, Brijeshwar Maini, MD, Cardiologist and Director of Cardiovascular Research and Education at PinnacleHealth, and Mubashir Mumtaz, MD, Chief of Cardiothoracic Surgery at PinnacleHealth, performed the first catheter-based valve repair with the MitraClip® in Pennsylvania following the device's FDA approval. The U.S. Food and...

2013-11-19 23:02:53

New Findings by Research Team, Including Researchers from Icahn School of Medicine at Mount Sinai, Showing Mitral Valve Replacement May Be More Effective Than Mitral Valve Repair Reported at AHA Scientific Sessions 2013 and in New England Journal of Medicine New York, NY (PRWEB) November 19, 2013 The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether...

2013-10-25 23:00:22

The Washington University and Barnes-Jewish Heart & Vascular Center was one of 47 centers nationwide to participate in the medical trial that led to approval of the device by the FDA. St. Louis (PRWEB) October 25, 2013 A device approved today by the Federal Drug Administration (FDA) to treat leaky mitral valves was first used in this region as part of a clinical trial at the Washington University and Barnes-Jewish Heart & Vascular Center. This new non-surgical alternative for...

2013-10-25 08:25:42

Treatment with Minimally Invasive Device Can Improve Quality of Life for Patients with Debilitating Mitral Valve Disease Who Are at Prohibitive Surgical Risk ABBOTT PARK, Ill., Oct. 25, 2013 /PRNewswire/ -- Abbott today announced that its first-in-class, catheter-based MitraClip(®) therapy has received U.S. Food and Drug Administration (FDA) approval and will launch immediately in the United States, providing physicians with a breakthrough treatment option for patients suffering...

2013-10-24 08:34:20

Neovasc's Tiara(TM) Program for the Transcatheter Treatment of Mitral Valve Disease Will Be Featured in Two Sessions VANCOUVER, Oct. 24, 2013 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that researchers will present data on the company's Tiara(TM) transcatheter mitral valve in preclinical development for the treatment of mitral valve disease at the upcoming 25(th) Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the...

2013-10-01 17:56:33

Mayo Clinic study examines costs following operating room and recovery improvement efforts The total hospital cost of mitral valve repair surgery — from the time a patient is admitted to the hospital until release — is similar, whether performed through small port incisions using robotic equipment or via the conventional open-chest method, a Mayo Clinic study of 370 patients found. Importantly, robotic surgeries were just as safe as conventional open procedures, but patients who...

2013-09-06 16:22:44

MOUNTAIN VIEW, Calif., Sept. 6, 2013 /PRNewswire/ -- Tenaxis Medical, Inc., (www.tenaxismedical.com), a medical device company focused on the development of functionally designed surgical sealants has received approval from its EU Notified Body, BSI, to expand its CE Mark indications for ArterX Surgical Sealant. ArterX Surgical Sealant is designed to be applied directly over suture or staple line to achieve hemostasis during surgery to seal the area to stop and prevent leaks. The...

2013-08-14 12:22:08

In a study that included patients with mitral valve regurgitation due to a condition known as flail mitral valve leaflets, performance of early surgical correction compared with initial medical management was associated with greater long-term survival and lower risk of heart failure, according to a study in the August 14 issue of JAMA. "Degenerative mitral regurgitation [backflow of blood from the left ventricle to the left atrium due to mitral valve insufficiency] is common and can be...